RESEARCH USE ONLY   |   NOT FOR HUMAN CONSUMPTION
ADVANCING PEPTIDE SCIENCE.
FREE UK DELIVERY £60+
Home  ›  Quality Assurance
QUALITY ASSURANCE

QUALITY YOU
CAN VERIFY.

Independent verification, batch traceability and clear documentation underpin the VOREVIA quality standard. Commercial stock is held in the UK and released only after our quality review is complete.

◇
RESEARCH GRADEQuality focused
⚗
QUALITY ASSURANCESupporting verification
🚚
TRACKED SHIPPINGUK & international
01INDEPENDENT TESTINGCommercial batches are independently assessed before release.
02BATCH TRACEABILITYDocumentation is linked to the batch to which it applies.
03UK-BASED STOCKReleased inventory is held in the UK for direct fulfilment.
The VOREVIA Standard

QUALITY BUILT AROUND EVIDENCE.

We believe confidence begins with knowing what supports a product. Supplier documentation can form part of our review, but VOREVIA does not rely solely on supplier-provided certificates when releasing commercial peptide stock.

Our aim is to provide research customers with a clear chain between the product supplied, its batch identity and the independent analytical information available for that material.

From Receipt to Release

OUR QUARANTINE & RELEASE PROCESS.

Commercial inventory is not released for sale simply because it has arrived. The process below is designed to separate receipt of stock from authorisation for sale.

01STOCK ARRIVESCommercial inventory is received and batch information recorded.
02QUARANTINEDStock remains segregated while the relevant quality checks are completed.
03SAMPLE SELECTEDA sample is taken from the commercial inventory intended for sale.
04INDEPENDENT TESTINGThe sample is submitted to an independent laboratory for the appropriate analysis.
05RESULTS REVIEWEDResults are reviewed against the relevant product and batch information.
06BATCH RELEASEDOnly after satisfactory review is the batch authorised for sale by VOREVIA.

This process refers to VOREVIA's commercial inventory. It is designed so that independent testing relates to material from the stock being supplied to customers, rather than relying on a generic certificate from a different batch.

What We Assess

MORE THAN A PURITY NUMBER.

Analytical information should be read in context. A high purity result alone does not establish every characteristic of a vial, which is why VOREVIA's quality review considers the evidence relevant to the product and batch.

01

IDENTITY

Analytical information can help confirm that the tested material corresponds with the stated compound.

02

PURITY

Purity analysis provides information about the proportion of the target compound in the tested sample.

03

QUANTITY / CONTENT

Where applicable, measured content helps verify the amount present rather than relying solely on the labelled vial quantity.

04

BATCH REFERENCE

Batch identification connects the available evidence to the specific commercial material to which it relates.

Batch Verification

VERIFY YOUR BATCH.

Use the product and batch reference shown on VOREVIA packaging to locate the corresponding released-batch record. Batch records are published only after the applicable quality review has been completed.

QRQR-READY VERIFICATION

Released batches can link directly to this verification section from a QR code on VOREVIA packaging, giving research customers a simple route from the physical product to its supporting batch record.

Independent Verification

WE DON'T RELY SOLELY ON SUPPLIER CERTIFICATES.

Supplier documentation is useful background information and can form part of our supplier and product review. It is not, by itself, the basis on which VOREVIA represents a commercial peptide batch as independently verified.

Where VOREVIA publishes an independent result for a released batch, the intention is that the evidence relates to material from the commercial inventory received for that batch.

Product-Specific Controls

BAC WATER.
DIFFERENT PRODUCT.
DIFFERENT QUALITY CONTROLS.

Bacteriostatic water is not assessed by simply applying the same analytical approach used for peptide identity or purity. VOREVIA treats it as a separate product category requiring an appropriate quality review.

Where testing is commissioned, the published batch documentation will identify the methods and results that actually apply to that BAC Water batch. We will not present a peptide-style HPLC purity result as a substitute for appropriate microbiological quality evidence.

Specific BAC Water release criteria and laboratory methods will be published when the applicable commercial batch has completed VOREVIA's quality process.
VOREVIA Retatrutide 20 mg vial showing example batch number RT260901 and expiry 12/09/2028
Traceability

FROM THE VIAL TO THE EVIDENCE.

Each released batch is intended to carry a clear batch reference that links the physical product supplied to the corresponding quality record available from VOREVIA.

  • Product identity and strength
  • Batch / lot reference
  • Release status
  • Independent laboratory result where applicable
  • Direct digital verification pathway
The VOREVIA Standard

INDEPENDENTLY TESTED.
BATCH TRACEABLE.
CLEARLY DOCUMENTED.

We will not present a quality claim as verified unless we have appropriate information to support it. Where documentation or testing applies only to a particular batch, that distinction matters.

Released stock is held in the UK and supported by the batch information available for that material.

VOREVIA products are supplied strictly for laboratory research purposes only. They are not intended for human consumption, therapeutic use, diagnostic use or veterinary use.

Explore the VOREVIA research collection.Shop Research Products →
VOREVIA research